Page last updated: 2024-11-11

c.i. fluorescent brightening agent 28

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4,4'-bis({4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino)stilbene-2,2'-disulfonic acid : An organosulfonic acid comprising stilbene having 4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino groups at the 4 and 4'-positions and sulfo groups at the 2- and 2'-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6108780
CHEMBL ID1256580
CHEBI ID50010
SCHEMBL ID790332
MeSH IDM0049998

Synonyms (45)

Synonym
AC-12935
fluorescent brightener 28, used as a stain and brightening agent
2,2'-stilbenedisulfonic acid, 4,4'-bis((4-anilino-6-(bis(2-hydroxyethyl)amino)-s-triazin-2-yl)amino)-
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4-(bis(2-hydroxyethyl)amino)-6-(phenylamino)-1,3,5-triazin-2-yl)amino)-
einecs 224-548-7
calcofluor m2r
4,4'-bis((4-anilino-6-(bis(2-hydroxyethyl)amino)-s-triazin-2-yl)amino)-2,2'-stilbene disulfonic acid
tinopal lpw
4,4'-bis((4-anilino-6-(bis(2-hydroxyethyl)amino)-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulfonic acid
fluorescent brightener 28
tinopal unpa-gx
calcofluor white m2r
4,4'-bis((4-(bis(2-hydroxyethyl)amino)-6-anilino-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulphonic acid
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-
4404-43-7
2,2'-(e)-ethene-1,2-diylbis[5-({4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino)benzenesulfonic acid]
c.i. fluorescent brightening agent 28
calcofluor
4193-55-9
4,4'-bis((4-anilino-6-(bis(2-hydroxyethyl)amino)-s-triazin-2-yl)amino)-2,2'-stilbenedisulfonic acid
4,4'-bis({4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino)stilbene-2,2'-disulfonic acid
calcofluor white
2,2'-ethene-1,2-diylbis[5-({4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino)benzenesulfonic acid]
CHEBI:50010
5-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid
fluorescent brightener
CHEMBL1256580
4,4'-bis(4-(bis(2-hydroxyethyl)amino)-6-anilino-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulphonic acid
ec 224-548-7
7s9p0y4313 ,
unii-7s9p0y4313
AKOS015894290
SCHEMBL790332
4,4'-bis(2-anilino-4-(bis(hydroxyethyl)amino)-s-triazin-6-ylamino)-2,2'-stilbenedisulfonic acid
fluorescent brightener 28 free acid
phorwite bbh
c.i. fluorescent brightening agent 28, (e)-
c.i. fluorescent brightener 28, free acid
4,4'-bis((4-anilino-6-bis((2-hydroxyethyl)amino)-s-triazin-2-yl)amino)-2,2'-stilbenedisulfonic acid
ci fluorescent brightening agent 28
6,6'-(ethene-1,2-diyl)bis(3-((4-(bis(2-hydroxyethyl)amino)-6-(phenylamino)-1,3,5-triazin-2-yl)amino)benzenesulfonic acid)
CNGYZEMWVAWWOB-VAWYXSNFSA-N
Q27121661
Q27268792
STARBLD0009593

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In time-course experiments using a dosage of 15 occlusions ( approximately LD(90)), lacZ expression marking the onset of primary and secondary infection was first observed in midgut columnar and tracheal cells at 4 and 12 h, respectively."( Comparative pathogenesis of Helicoverpa zea S nucleopolyhedrovirus in noctuid larvae.
Volkman, LE; Washburn, JO; Wong, JF, 2001
)
0.31
" PI(4,5)P2 levels increased in a dose-response manner at caspofungin concentrations of ≤4× MIC and progressively decreased at concentrations of ≥8× MIC."( Highly Dynamic and Specific Phosphatidylinositol 4,5-Bisphosphate, Septin, and Cell Wall Integrity Pathway Responses Correlate with Caspofungin Activity against Candida albicans.
Badrane, H; Clancy, CJ; Nguyen, MH, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID522114Antimicrobial activity against Candida glabrata TG162 containing calcineurin deltacnb1 mutant at 0.8 mg/ml after 48 hrs2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
AID522113Antimicrobial activity against Candida glabrata TG172 containing deltacrz1 mutant at 0.8 mg/ml after 48 hrs2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (321)

TimeframeStudies, This Drug (%)All Drugs %
pre-199026 (8.10)18.7374
1990's62 (19.31)18.2507
2000's114 (35.51)29.6817
2010's94 (29.28)24.3611
2020's25 (7.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.02 (24.57)
Research Supply Index5.84 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.88%)5.53%
Reviews6 (1.76%)6.00%
Case Studies6 (1.76%)4.05%
Observational0 (0.00%)0.25%
Other326 (95.60%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]